Sociodemographic Factors Associated with Treatment for COVID-19 and Their Relationship with Short-Term Acute Care Utilization (Infusion Journal)
-
Register
- Prices available after logging in
Health disparities have been exacerbated during the COVID-19 pandemic. Despite COVID-19 treatments being associated with lower morbidity and mortality, recent data illustrates that treatment may be underutilized by certain patient populations. This study examines patient sociodemographic and clinical characteristics and their relation to COVID-19 treatment, focusing on intravenous bebtelovimab, oral nirmatrelvir/ritonavir, or no treatment; data is extrapolated to further understand the relationship of treatment and patient characteristics on short-term acute care outcomes.
Kassie Klasen, PharmD
PGY1 Pharmacy Resident
Fairview Pharmacy Services
Kassie Klasen, PharmD is a PGY1 Ambulatory Pharmacy Resident at M Health Fairview in Minneapolis, Minnesota. She graduated in 2022 from the University of Minnesota College of Pharmacy. Throughout pharmacy school, she worked as a pharmacy intern at an ambulatory infusion center. She currently staffs at Fairview Home Infusion and has completed residency rotations with several ambulatory pharmacies within the health system.
No Disclosures to Report
Alicia Zagel, PhD MPH
Fairview Pharmacy Services
No Disclosures to Report
Mary Nelson, PharmD
Fairview Pharmacy Services
No Disclosures to Report
Eric Betzold, MS
Fairview Pharmacy Services
No Disclosures to Report
Brett Benfield, PharmD, MS, FNHIA
Director of Home Infusion & Compounding
Fairview Pharmacy Services
Brett Benfield PharmD, MS, FNHIA has worked for MHealth Fairview since 2014 serving in several capacities including his current role as Director of Pharmacy for Fairview Home Infusion and 503A Compounding.
No Disclosures to Report